Bio-pharma Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Bio-pharma in global, including the following market information:
Global Bio-pharma Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bio-pharma Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Bio-pharma companies in 2021 (%)
The global Bio-pharma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bio-pharma include Pfizer, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Sanofi, Amgen, AbbVie, Merck & Co., Inc, Biogen Idec, Bayer AG and Eli Lilly and Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bio-pharma manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bio-pharma Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Bio-pharma Market Segment Percentages, by Type, 2021 (%)
Global Bio-pharma Market Segment Percentages, by Application, 2021 (%)
Global Bio-pharma Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Bio-pharma revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bio-pharma revenues share in global market, 2021 (%)
Key companies Bio-pharma sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Bio-pharma sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Bio-pharma Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bio-pharma Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Bio-pharma companies in 2021 (%)
The global Bio-pharma market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bio-pharma include Pfizer, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Sanofi, Amgen, AbbVie, Merck & Co., Inc, Biogen Idec, Bayer AG and Eli Lilly and Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bio-pharma manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bio-pharma Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Bio-pharma Market Segment Percentages, by Type, 2021 (%)
- Monoclonal Antibodies
- Recombinant Proteins
- Granulocyte-Colony Stimulating Factor (G-CSF)
- Interferons
- Recombinant Human Insulin
- Erythropoietin
- Vaccines
- Growth Hormones
- Purified Proteins
- Others
Global Bio-pharma Market Segment Percentages, by Application, 2021 (%)
- Metabolic Disorders
- Oncology
- Neurological Disorders
- Cardiovascular Diseases
- Inflammatory and Infectious Diseases
- Others
Global Bio-pharma Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Bio-pharma revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bio-pharma revenues share in global market, 2021 (%)
Key companies Bio-pharma sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Bio-pharma sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- F. Hoffmann-La Roche AG
- Johnson & Johnson Services
- Sanofi, Amgen
- AbbVie
- Merck & Co., Inc
- Biogen Idec
- Bayer AG
- Eli Lilly and Company
- Novartis AG GlaxoSmithKline Plc
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Abbott Laboratories
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Bio-pharma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bio-pharma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIO-PHARMA OVERALL MARKET SIZE
2.1 Global Bio-pharma Market Size: 2021 VS 2028
2.2 Global Bio-pharma Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bio-pharma Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Bio-pharma Players in Global Market
3.2 Top Global Bio-pharma Companies Ranked by Revenue
3.3 Global Bio-pharma Revenue by Companies
3.4 Global Bio-pharma Sales by Companies
3.5 Global Bio-pharma Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bio-pharma Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bio-pharma Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bio-pharma Players in Global Market
3.8.1 List of Global Tier 1 Bio-pharma Companies
3.8.2 List of Global Tier 2 and Tier 3 Bio-pharma Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Bio-pharma Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Recombinant Proteins
4.1.4 Granulocyte-Colony Stimulating Factor (G-CSF)
4.1.5 Interferons
4.1.6 Recombinant Human Insulin
4.1.7 Erythropoietin
4.1.8 Vaccines
4.1.9 Growth Hormones
4.1.10 Purified Proteins
4.1.11 Others
4.2 By Type - Global Bio-pharma Revenue & Forecasts
4.2.1 By Type - Global Bio-pharma Revenue, 2017-2022
4.2.2 By Type - Global Bio-pharma Revenue, 2023-2028
4.2.3 By Type - Global Bio-pharma Revenue Market Share, 2017-2028
4.3 By Type - Global Bio-pharma Sales & Forecasts
4.3.1 By Type - Global Bio-pharma Sales, 2017-2022
4.3.2 By Type - Global Bio-pharma Sales, 2023-2028
4.3.3 By Type - Global Bio-pharma Sales Market Share, 2017-2028
4.4 By Type - Global Bio-pharma Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Bio-pharma Market Size, 2021 & 2028
5.1.2 Metabolic Disorders
5.1.3 Oncology
5.1.4 Neurological Disorders
5.1.5 Cardiovascular Diseases
5.1.6 Inflammatory and Infectious Diseases
5.1.7 Others
5.2 By Application - Global Bio-pharma Revenue & Forecasts
5.2.1 By Application - Global Bio-pharma Revenue, 2017-2022
5.2.2 By Application - Global Bio-pharma Revenue, 2023-2028
5.2.3 By Application - Global Bio-pharma Revenue Market Share, 2017-2028
5.3 By Application - Global Bio-pharma Sales & Forecasts
5.3.1 By Application - Global Bio-pharma Sales, 2017-2022
5.3.2 By Application - Global Bio-pharma Sales, 2023-2028
5.3.3 By Application - Global Bio-pharma Sales Market Share, 2017-2028
5.4 By Application - Global Bio-pharma Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Bio-pharma Market Size, 2021 & 2028
6.2 By Region - Global Bio-pharma Revenue & Forecasts
6.2.1 By Region - Global Bio-pharma Revenue, 2017-2022
6.2.2 By Region - Global Bio-pharma Revenue, 2023-2028
6.2.3 By Region - Global Bio-pharma Revenue Market Share, 2017-2028
6.3 By Region - Global Bio-pharma Sales & Forecasts
6.3.1 By Region - Global Bio-pharma Sales, 2017-2022
6.3.2 By Region - Global Bio-pharma Sales, 2023-2028
6.3.3 By Region - Global Bio-pharma Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Bio-pharma Revenue, 2017-2028
6.4.2 By Country - North America Bio-pharma Sales, 2017-2028
6.4.3 US Bio-pharma Market Size, 2017-2028
6.4.4 Canada Bio-pharma Market Size, 2017-2028
6.4.5 Mexico Bio-pharma Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Bio-pharma Revenue, 2017-2028
6.5.2 By Country - Europe Bio-pharma Sales, 2017-2028
6.5.3 Germany Bio-pharma Market Size, 2017-2028
6.5.4 France Bio-pharma Market Size, 2017-2028
6.5.5 U.K. Bio-pharma Market Size, 2017-2028
6.5.6 Italy Bio-pharma Market Size, 2017-2028
6.5.7 Russia Bio-pharma Market Size, 2017-2028
6.5.8 Nordic Countries Bio-pharma Market Size, 2017-2028
6.5.9 Benelux Bio-pharma Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Bio-pharma Revenue, 2017-2028
6.6.2 By Region - Asia Bio-pharma Sales, 2017-2028
6.6.3 China Bio-pharma Market Size, 2017-2028
6.6.4 Japan Bio-pharma Market Size, 2017-2028
6.6.5 South Korea Bio-pharma Market Size, 2017-2028
6.6.6 Southeast Asia Bio-pharma Market Size, 2017-2028
6.6.7 India Bio-pharma Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Bio-pharma Revenue, 2017-2028
6.7.2 By Country - South America Bio-pharma Sales, 2017-2028
6.7.3 Brazil Bio-pharma Market Size, 2017-2028
6.7.4 Argentina Bio-pharma Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bio-pharma Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Bio-pharma Sales, 2017-2028
6.8.3 Turkey Bio-pharma Market Size, 2017-2028
6.8.4 Israel Bio-pharma Market Size, 2017-2028
6.8.5 Saudi Arabia Bio-pharma Market Size, 2017-2028
6.8.6 UAE Bio-pharma Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Bio-pharma Major Product Offerings
7.1.4 Pfizer Bio-pharma Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 F. Hoffmann-La Roche AG
7.2.1 F. Hoffmann-La Roche AG Corporate Summary
7.2.2 F. Hoffmann-La Roche AG Business Overview
7.2.3 F. Hoffmann-La Roche AG Bio-pharma Major Product Offerings
7.2.4 F. Hoffmann-La Roche AG Bio-pharma Sales and Revenue in Global (2017-2022)
7.2.5 F. Hoffmann-La Roche AG Key News
7.3 Johnson & Johnson Services
7.3.1 Johnson & Johnson Services Corporate Summary
7.3.2 Johnson & Johnson Services Business Overview
7.3.3 Johnson & Johnson Services Bio-pharma Major Product Offerings
7.3.4 Johnson & Johnson Services Bio-pharma Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Services Key News
7.4 Sanofi, Amgen
7.4.1 Sanofi, Amgen Corporate Summary
7.4.2 Sanofi, Amgen Business Overview
7.4.3 Sanofi, Amgen Bio-pharma Major Product Offerings
7.4.4 Sanofi, Amgen Bio-pharma Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi, Amgen Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Bio-pharma Major Product Offerings
7.5.4 AbbVie Bio-pharma Sales and Revenue in Global (2017-2022)
7.5.5 AbbVie Key News
7.6 Merck & Co., Inc
7.6.1 Merck & Co., Inc Corporate Summary
7.6.2 Merck & Co., Inc Business Overview
7.6.3 Merck & Co., Inc Bio-pharma Major Product Offerings
7.6.4 Merck & Co., Inc Bio-pharma Sales and Revenue in Global (2017-2022)
7.6.5 Merck & Co., Inc Key News
7.7 Biogen Idec
7.7.1 Biogen Idec Corporate Summary
7.7.2 Biogen Idec Business Overview
7.7.3 Biogen Idec Bio-pharma Major Product Offerings
7.7.4 Biogen Idec Bio-pharma Sales and Revenue in Global (2017-2022)
7.7.5 Biogen Idec Key News
7.8 Bayer AG
7.8.1 Bayer AG Corporate Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Bio-pharma Major Product Offerings
7.8.4 Bayer AG Bio-pharma Sales and Revenue in Global (2017-2022)
7.8.5 Bayer AG Key News
7.9 Eli Lilly and Company
7.9.1 Eli Lilly and Company Corporate Summary
7.9.2 Eli Lilly and Company Business Overview
7.9.3 Eli Lilly and Company Bio-pharma Major Product Offerings
7.9.4 Eli Lilly and Company Bio-pharma Sales and Revenue in Global (2017-2022)
7.9.5 Eli Lilly and Company Key News
7.10 Novartis AG GlaxoSmithKline Plc
7.10.1 Novartis AG GlaxoSmithKline Plc Corporate Summary
7.10.2 Novartis AG GlaxoSmithKline Plc Business Overview
7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Major Product Offerings
7.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales and Revenue in Global (2017-2022)
7.10.5 Novartis AG GlaxoSmithKline Plc Key News
7.11 Bristol-Myers Squibb Company
7.11.1 Bristol-Myers Squibb Company Corporate Summary
7.11.2 Bristol-Myers Squibb Company Bio-pharma Business Overview
7.11.3 Bristol-Myers Squibb Company Bio-pharma Major Product Offerings
7.11.4 Bristol-Myers Squibb Company Bio-pharma Sales and Revenue in Global (2017-2022)
7.11.5 Bristol-Myers Squibb Company Key News
7.12 AstraZeneca PLC
7.12.1 AstraZeneca PLC Corporate Summary
7.12.2 AstraZeneca PLC Bio-pharma Business Overview
7.12.3 AstraZeneca PLC Bio-pharma Major Product Offerings
7.12.4 AstraZeneca PLC Bio-pharma Sales and Revenue in Global (2017-2022)
7.12.5 AstraZeneca PLC Key News
7.13 Abbott Laboratories
7.13.1 Abbott Laboratories Corporate Summary
7.13.2 Abbott Laboratories Bio-pharma Business Overview
7.13.3 Abbott Laboratories Bio-pharma Major Product Offerings
7.13.4 Abbott Laboratories Bio-pharma Sales and Revenue in Global (2017-2022)
7.13.5 Abbott Laboratories Key News
8 GLOBAL BIO-PHARMA PRODUCTION CAPACITY, ANALYSIS
8.1 Global Bio-pharma Production Capacity, 2017-2028
8.2 Bio-pharma Production Capacity of Key Manufacturers in Global Market
8.3 Global Bio-pharma Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BIO-PHARMA SUPPLY CHAIN ANALYSIS
10.1 Bio-pharma Industry Value Chain
10.2 Bio-pharma Upstream Market
10.3 Bio-pharma Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bio-pharma Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Bio-pharma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bio-pharma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL BIO-PHARMA OVERALL MARKET SIZE
2.1 Global Bio-pharma Market Size: 2021 VS 2028
2.2 Global Bio-pharma Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bio-pharma Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Bio-pharma Players in Global Market
3.2 Top Global Bio-pharma Companies Ranked by Revenue
3.3 Global Bio-pharma Revenue by Companies
3.4 Global Bio-pharma Sales by Companies
3.5 Global Bio-pharma Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bio-pharma Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bio-pharma Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bio-pharma Players in Global Market
3.8.1 List of Global Tier 1 Bio-pharma Companies
3.8.2 List of Global Tier 2 and Tier 3 Bio-pharma Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Bio-pharma Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Recombinant Proteins
4.1.4 Granulocyte-Colony Stimulating Factor (G-CSF)
4.1.5 Interferons
4.1.6 Recombinant Human Insulin
4.1.7 Erythropoietin
4.1.8 Vaccines
4.1.9 Growth Hormones
4.1.10 Purified Proteins
4.1.11 Others
4.2 By Type - Global Bio-pharma Revenue & Forecasts
4.2.1 By Type - Global Bio-pharma Revenue, 2017-2022
4.2.2 By Type - Global Bio-pharma Revenue, 2023-2028
4.2.3 By Type - Global Bio-pharma Revenue Market Share, 2017-2028
4.3 By Type - Global Bio-pharma Sales & Forecasts
4.3.1 By Type - Global Bio-pharma Sales, 2017-2022
4.3.2 By Type - Global Bio-pharma Sales, 2023-2028
4.3.3 By Type - Global Bio-pharma Sales Market Share, 2017-2028
4.4 By Type - Global Bio-pharma Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Bio-pharma Market Size, 2021 & 2028
5.1.2 Metabolic Disorders
5.1.3 Oncology
5.1.4 Neurological Disorders
5.1.5 Cardiovascular Diseases
5.1.6 Inflammatory and Infectious Diseases
5.1.7 Others
5.2 By Application - Global Bio-pharma Revenue & Forecasts
5.2.1 By Application - Global Bio-pharma Revenue, 2017-2022
5.2.2 By Application - Global Bio-pharma Revenue, 2023-2028
5.2.3 By Application - Global Bio-pharma Revenue Market Share, 2017-2028
5.3 By Application - Global Bio-pharma Sales & Forecasts
5.3.1 By Application - Global Bio-pharma Sales, 2017-2022
5.3.2 By Application - Global Bio-pharma Sales, 2023-2028
5.3.3 By Application - Global Bio-pharma Sales Market Share, 2017-2028
5.4 By Application - Global Bio-pharma Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Bio-pharma Market Size, 2021 & 2028
6.2 By Region - Global Bio-pharma Revenue & Forecasts
6.2.1 By Region - Global Bio-pharma Revenue, 2017-2022
6.2.2 By Region - Global Bio-pharma Revenue, 2023-2028
6.2.3 By Region - Global Bio-pharma Revenue Market Share, 2017-2028
6.3 By Region - Global Bio-pharma Sales & Forecasts
6.3.1 By Region - Global Bio-pharma Sales, 2017-2022
6.3.2 By Region - Global Bio-pharma Sales, 2023-2028
6.3.3 By Region - Global Bio-pharma Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Bio-pharma Revenue, 2017-2028
6.4.2 By Country - North America Bio-pharma Sales, 2017-2028
6.4.3 US Bio-pharma Market Size, 2017-2028
6.4.4 Canada Bio-pharma Market Size, 2017-2028
6.4.5 Mexico Bio-pharma Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Bio-pharma Revenue, 2017-2028
6.5.2 By Country - Europe Bio-pharma Sales, 2017-2028
6.5.3 Germany Bio-pharma Market Size, 2017-2028
6.5.4 France Bio-pharma Market Size, 2017-2028
6.5.5 U.K. Bio-pharma Market Size, 2017-2028
6.5.6 Italy Bio-pharma Market Size, 2017-2028
6.5.7 Russia Bio-pharma Market Size, 2017-2028
6.5.8 Nordic Countries Bio-pharma Market Size, 2017-2028
6.5.9 Benelux Bio-pharma Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Bio-pharma Revenue, 2017-2028
6.6.2 By Region - Asia Bio-pharma Sales, 2017-2028
6.6.3 China Bio-pharma Market Size, 2017-2028
6.6.4 Japan Bio-pharma Market Size, 2017-2028
6.6.5 South Korea Bio-pharma Market Size, 2017-2028
6.6.6 Southeast Asia Bio-pharma Market Size, 2017-2028
6.6.7 India Bio-pharma Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Bio-pharma Revenue, 2017-2028
6.7.2 By Country - South America Bio-pharma Sales, 2017-2028
6.7.3 Brazil Bio-pharma Market Size, 2017-2028
6.7.4 Argentina Bio-pharma Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bio-pharma Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Bio-pharma Sales, 2017-2028
6.8.3 Turkey Bio-pharma Market Size, 2017-2028
6.8.4 Israel Bio-pharma Market Size, 2017-2028
6.8.5 Saudi Arabia Bio-pharma Market Size, 2017-2028
6.8.6 UAE Bio-pharma Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Bio-pharma Major Product Offerings
7.1.4 Pfizer Bio-pharma Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 F. Hoffmann-La Roche AG
7.2.1 F. Hoffmann-La Roche AG Corporate Summary
7.2.2 F. Hoffmann-La Roche AG Business Overview
7.2.3 F. Hoffmann-La Roche AG Bio-pharma Major Product Offerings
7.2.4 F. Hoffmann-La Roche AG Bio-pharma Sales and Revenue in Global (2017-2022)
7.2.5 F. Hoffmann-La Roche AG Key News
7.3 Johnson & Johnson Services
7.3.1 Johnson & Johnson Services Corporate Summary
7.3.2 Johnson & Johnson Services Business Overview
7.3.3 Johnson & Johnson Services Bio-pharma Major Product Offerings
7.3.4 Johnson & Johnson Services Bio-pharma Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Services Key News
7.4 Sanofi, Amgen
7.4.1 Sanofi, Amgen Corporate Summary
7.4.2 Sanofi, Amgen Business Overview
7.4.3 Sanofi, Amgen Bio-pharma Major Product Offerings
7.4.4 Sanofi, Amgen Bio-pharma Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi, Amgen Key News
7.5 AbbVie
7.5.1 AbbVie Corporate Summary
7.5.2 AbbVie Business Overview
7.5.3 AbbVie Bio-pharma Major Product Offerings
7.5.4 AbbVie Bio-pharma Sales and Revenue in Global (2017-2022)
7.5.5 AbbVie Key News
7.6 Merck & Co., Inc
7.6.1 Merck & Co., Inc Corporate Summary
7.6.2 Merck & Co., Inc Business Overview
7.6.3 Merck & Co., Inc Bio-pharma Major Product Offerings
7.6.4 Merck & Co., Inc Bio-pharma Sales and Revenue in Global (2017-2022)
7.6.5 Merck & Co., Inc Key News
7.7 Biogen Idec
7.7.1 Biogen Idec Corporate Summary
7.7.2 Biogen Idec Business Overview
7.7.3 Biogen Idec Bio-pharma Major Product Offerings
7.7.4 Biogen Idec Bio-pharma Sales and Revenue in Global (2017-2022)
7.7.5 Biogen Idec Key News
7.8 Bayer AG
7.8.1 Bayer AG Corporate Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Bio-pharma Major Product Offerings
7.8.4 Bayer AG Bio-pharma Sales and Revenue in Global (2017-2022)
7.8.5 Bayer AG Key News
7.9 Eli Lilly and Company
7.9.1 Eli Lilly and Company Corporate Summary
7.9.2 Eli Lilly and Company Business Overview
7.9.3 Eli Lilly and Company Bio-pharma Major Product Offerings
7.9.4 Eli Lilly and Company Bio-pharma Sales and Revenue in Global (2017-2022)
7.9.5 Eli Lilly and Company Key News
7.10 Novartis AG GlaxoSmithKline Plc
7.10.1 Novartis AG GlaxoSmithKline Plc Corporate Summary
7.10.2 Novartis AG GlaxoSmithKline Plc Business Overview
7.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Major Product Offerings
7.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales and Revenue in Global (2017-2022)
7.10.5 Novartis AG GlaxoSmithKline Plc Key News
7.11 Bristol-Myers Squibb Company
7.11.1 Bristol-Myers Squibb Company Corporate Summary
7.11.2 Bristol-Myers Squibb Company Bio-pharma Business Overview
7.11.3 Bristol-Myers Squibb Company Bio-pharma Major Product Offerings
7.11.4 Bristol-Myers Squibb Company Bio-pharma Sales and Revenue in Global (2017-2022)
7.11.5 Bristol-Myers Squibb Company Key News
7.12 AstraZeneca PLC
7.12.1 AstraZeneca PLC Corporate Summary
7.12.2 AstraZeneca PLC Bio-pharma Business Overview
7.12.3 AstraZeneca PLC Bio-pharma Major Product Offerings
7.12.4 AstraZeneca PLC Bio-pharma Sales and Revenue in Global (2017-2022)
7.12.5 AstraZeneca PLC Key News
7.13 Abbott Laboratories
7.13.1 Abbott Laboratories Corporate Summary
7.13.2 Abbott Laboratories Bio-pharma Business Overview
7.13.3 Abbott Laboratories Bio-pharma Major Product Offerings
7.13.4 Abbott Laboratories Bio-pharma Sales and Revenue in Global (2017-2022)
7.13.5 Abbott Laboratories Key News
8 GLOBAL BIO-PHARMA PRODUCTION CAPACITY, ANALYSIS
8.1 Global Bio-pharma Production Capacity, 2017-2028
8.2 Bio-pharma Production Capacity of Key Manufacturers in Global Market
8.3 Global Bio-pharma Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BIO-PHARMA SUPPLY CHAIN ANALYSIS
10.1 Bio-pharma Industry Value Chain
10.2 Bio-pharma Upstream Market
10.3 Bio-pharma Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bio-pharma Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Bio-pharma in Global Market
Table 2. Top Bio-pharma Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bio-pharma Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bio-pharma Revenue Share by Companies, 2017-2022
Table 5. Global Bio-pharma Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Bio-pharma Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bio-pharma Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Bio-pharma Product Type
Table 9. List of Global Tier 1 Bio-pharma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bio-pharma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bio-pharma Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bio-pharma Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bio-pharma Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bio-pharma Sales (K Pcs), 2017-2022
Table 15. By Type - Global Bio-pharma Sales (K Pcs), 2023-2028
Table 16. By Application – Global Bio-pharma Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bio-pharma Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bio-pharma Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bio-pharma Sales (K Pcs), 2017-2022
Table 20. By Application - Global Bio-pharma Sales (K Pcs), 2023-2028
Table 21. By Region – Global Bio-pharma Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bio-pharma Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bio-pharma Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bio-pharma Sales (K Pcs), 2017-2022
Table 25. By Region - Global Bio-pharma Sales (K Pcs), 2023-2028
Table 26. By Country - North America Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bio-pharma Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Bio-pharma Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bio-pharma Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Bio-pharma Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bio-pharma Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Bio-pharma Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bio-pharma Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Bio-pharma Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bio-pharma Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Bio-pharma Sales, (K Pcs), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Bio-pharma Product Offerings
Table 48. Pfizer Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. F. Hoffmann-La Roche AG Corporate Summary
Table 50. F. Hoffmann-La Roche AG Bio-pharma Product Offerings
Table 51. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Johnson & Johnson Services Corporate Summary
Table 53. Johnson & Johnson Services Bio-pharma Product Offerings
Table 54. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Sanofi, Amgen Corporate Summary
Table 56. Sanofi, Amgen Bio-pharma Product Offerings
Table 57. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. AbbVie Corporate Summary
Table 59. AbbVie Bio-pharma Product Offerings
Table 60. AbbVie Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Merck & Co., Inc Corporate Summary
Table 62. Merck & Co., Inc Bio-pharma Product Offerings
Table 63. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Biogen Idec Corporate Summary
Table 65. Biogen Idec Bio-pharma Product Offerings
Table 66. Biogen Idec Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Bayer AG Corporate Summary
Table 68. Bayer AG Bio-pharma Product Offerings
Table 69. Bayer AG Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Eli Lilly and Company Corporate Summary
Table 71. Eli Lilly and Company Bio-pharma Product Offerings
Table 72. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Novartis AG GlaxoSmithKline Plc Corporate Summary
Table 74. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Offerings
Table 75. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Bristol-Myers Squibb Company Corporate Summary
Table 77. Bristol-Myers Squibb Company Bio-pharma Product Offerings
Table 78. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. AstraZeneca PLC Corporate Summary
Table 80. AstraZeneca PLC Bio-pharma Product Offerings
Table 81. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Abbott Laboratories Corporate Summary
Table 83. Abbott Laboratories Bio-pharma Product Offerings
Table 84. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Bio-pharma Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 86. Global Bio-pharma Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Bio-pharma Production by Region, 2017-2022 (K Pcs)
Table 88. Global Bio-pharma Production by Region, 2023-2028 (K Pcs)
Table 89. Bio-pharma Market Opportunities & Trends in Global Market
Table 90. Bio-pharma Market Drivers in Global Market
Table 91. Bio-pharma Market Restraints in Global Market
Table 92. Bio-pharma Raw Materials
Table 93. Bio-pharma Raw Materials Suppliers in Global Market
Table 94. Typical Bio-pharma Downstream
Table 95. Bio-pharma Downstream Clients in Global Market
Table 96. Bio-pharma Distributors and Sales Agents in Global Market
Table 1. Key Players of Bio-pharma in Global Market
Table 2. Top Bio-pharma Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bio-pharma Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bio-pharma Revenue Share by Companies, 2017-2022
Table 5. Global Bio-pharma Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Bio-pharma Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bio-pharma Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Bio-pharma Product Type
Table 9. List of Global Tier 1 Bio-pharma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bio-pharma Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bio-pharma Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bio-pharma Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bio-pharma Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bio-pharma Sales (K Pcs), 2017-2022
Table 15. By Type - Global Bio-pharma Sales (K Pcs), 2023-2028
Table 16. By Application – Global Bio-pharma Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bio-pharma Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bio-pharma Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bio-pharma Sales (K Pcs), 2017-2022
Table 20. By Application - Global Bio-pharma Sales (K Pcs), 2023-2028
Table 21. By Region – Global Bio-pharma Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bio-pharma Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bio-pharma Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bio-pharma Sales (K Pcs), 2017-2022
Table 25. By Region - Global Bio-pharma Sales (K Pcs), 2023-2028
Table 26. By Country - North America Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bio-pharma Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Bio-pharma Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bio-pharma Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Bio-pharma Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bio-pharma Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Bio-pharma Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bio-pharma Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Bio-pharma Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Bio-pharma Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bio-pharma Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bio-pharma Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Bio-pharma Sales, (K Pcs), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Bio-pharma Product Offerings
Table 48. Pfizer Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. F. Hoffmann-La Roche AG Corporate Summary
Table 50. F. Hoffmann-La Roche AG Bio-pharma Product Offerings
Table 51. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Johnson & Johnson Services Corporate Summary
Table 53. Johnson & Johnson Services Bio-pharma Product Offerings
Table 54. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Sanofi, Amgen Corporate Summary
Table 56. Sanofi, Amgen Bio-pharma Product Offerings
Table 57. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. AbbVie Corporate Summary
Table 59. AbbVie Bio-pharma Product Offerings
Table 60. AbbVie Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Merck & Co., Inc Corporate Summary
Table 62. Merck & Co., Inc Bio-pharma Product Offerings
Table 63. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Biogen Idec Corporate Summary
Table 65. Biogen Idec Bio-pharma Product Offerings
Table 66. Biogen Idec Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Bayer AG Corporate Summary
Table 68. Bayer AG Bio-pharma Product Offerings
Table 69. Bayer AG Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Eli Lilly and Company Corporate Summary
Table 71. Eli Lilly and Company Bio-pharma Product Offerings
Table 72. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Novartis AG GlaxoSmithKline Plc Corporate Summary
Table 74. Novartis AG GlaxoSmithKline Plc Bio-pharma Product Offerings
Table 75. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Bristol-Myers Squibb Company Corporate Summary
Table 77. Bristol-Myers Squibb Company Bio-pharma Product Offerings
Table 78. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. AstraZeneca PLC Corporate Summary
Table 80. AstraZeneca PLC Bio-pharma Product Offerings
Table 81. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Abbott Laboratories Corporate Summary
Table 83. Abbott Laboratories Bio-pharma Product Offerings
Table 84. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Bio-pharma Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 86. Global Bio-pharma Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Bio-pharma Production by Region, 2017-2022 (K Pcs)
Table 88. Global Bio-pharma Production by Region, 2023-2028 (K Pcs)
Table 89. Bio-pharma Market Opportunities & Trends in Global Market
Table 90. Bio-pharma Market Drivers in Global Market
Table 91. Bio-pharma Market Restraints in Global Market
Table 92. Bio-pharma Raw Materials
Table 93. Bio-pharma Raw Materials Suppliers in Global Market
Table 94. Typical Bio-pharma Downstream
Table 95. Bio-pharma Downstream Clients in Global Market
Table 96. Bio-pharma Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Bio-pharma Segment by Type
Figure 2. Bio-pharma Segment by Application
Figure 3. Global Bio-pharma Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bio-pharma Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bio-pharma Revenue, 2017-2028 (US$, Mn)
Figure 7. Bio-pharma Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Bio-pharma Revenue in 2021
Figure 9. By Type - Global Bio-pharma Sales Market Share, 2017-2028
Figure 10. By Type - Global Bio-pharma Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bio-pharma Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Bio-pharma Sales Market Share, 2017-2028
Figure 13. By Application - Global Bio-pharma Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bio-pharma Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Bio-pharma Sales Market Share, 2017-2028
Figure 16. By Region - Global Bio-pharma Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bio-pharma Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bio-pharma Sales Market Share, 2017-2028
Figure 19. US Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bio-pharma Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bio-pharma Sales Market Share, 2017-2028
Figure 24. Germany Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 25. France Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bio-pharma Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bio-pharma Sales Market Share, 2017-2028
Figure 33. China Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 37. India Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bio-pharma Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bio-pharma Sales Market Share, 2017-2028
Figure 40. Brazil Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bio-pharma Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bio-pharma Sales Market Share, 2017-2028
Figure 44. Turkey Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bio-pharma Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Bio-pharma by Region, 2021 VS 2028
Figure 50. Bio-pharma Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Bio-pharma Segment by Type
Figure 2. Bio-pharma Segment by Application
Figure 3. Global Bio-pharma Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bio-pharma Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bio-pharma Revenue, 2017-2028 (US$, Mn)
Figure 7. Bio-pharma Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Bio-pharma Revenue in 2021
Figure 9. By Type - Global Bio-pharma Sales Market Share, 2017-2028
Figure 10. By Type - Global Bio-pharma Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bio-pharma Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Bio-pharma Sales Market Share, 2017-2028
Figure 13. By Application - Global Bio-pharma Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bio-pharma Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Bio-pharma Sales Market Share, 2017-2028
Figure 16. By Region - Global Bio-pharma Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bio-pharma Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bio-pharma Sales Market Share, 2017-2028
Figure 19. US Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bio-pharma Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bio-pharma Sales Market Share, 2017-2028
Figure 24. Germany Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 25. France Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bio-pharma Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bio-pharma Sales Market Share, 2017-2028
Figure 33. China Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 37. India Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bio-pharma Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bio-pharma Sales Market Share, 2017-2028
Figure 40. Brazil Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bio-pharma Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bio-pharma Sales Market Share, 2017-2028
Figure 44. Turkey Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bio-pharma Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bio-pharma Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Bio-pharma by Region, 2021 VS 2028
Figure 50. Bio-pharma Industry Value Chain
Figure 51. Marketing Channels
